6.79 (-%)
As of Nov 21, 2024
Source:
Annovis Bio, Inc. is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer’s disease and Parkinson’s disease. We are developing our lead product candidate, Buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases.
Country | United States |
Headquarters | berwyn, pennsylvania |
Phone Number | 610-727-3913 |
Industry | manufacturing |
CEO | Maria Maccecchini |
Website | www.annovisbio.com |